KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Equity Income (2016 - 2025)

Opko Health's Equity Income history spans 14 years, with the latest figure at -$17000.0 for Q4 2025.

  • For Q4 2025, Equity Income changed N/A year-over-year to -$17000.0; the TTM value through Dec 2025 reached -$29000.0, changed N/A, while the annual FY2025 figure was -$29000.0, 61.11% down from the prior year.
  • Equity Income reached -$17000.0 in Q4 2025 per OPK's latest filing, down from -$3000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$1000.0 in Q2 2024 to a low of -$466000.0 in Q4 2021.
  • Average Equity Income over 5 years is -$64222.2, with a median of -$30500.0 recorded in 2022.
  • Peak YoY movement for Equity Income: tumbled 891.49% in 2021, then skyrocketed 97.62% in 2024.
  • A 5-year view of Equity Income shows it stood at -$466000.0 in 2021, then soared by 94.85% to -$24000.0 in 2022, then surged by 66.67% to -$8000.0 in 2023, then soared by 62.5% to -$3000.0 in 2024, then plummeted by 466.67% to -$17000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPK's Equity Income are -$17000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$9000.0 (Q1 2025).